Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Michael Elliott Weinblatt, M.D.

Co-Author

This page shows the publications co-authored by Michael Weinblatt and Nancy Shadick.
Connection Strength

6.757
  1. The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry. Clin Rheumatol. 2019 Nov; 38(11):3081-3092.
    View in: PubMed
    Score: 0.849
  2. Data-Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women's Rheumatoid Arthritis Sequential Study Registry. Arthritis Care Res (Hoboken). 2021 04; 73(4):471-480.
    View in: PubMed
    Score: 0.238
  3. Association of Seropositivity and Mortality in Rheumatoid Arthritis and the Impact of Treatment With Disease-Modifying Antirheumatic Drugs: Results From a Real-World Study. Arthritis Care Res (Hoboken). 2020 02; 72(2):176-183.
    View in: PubMed
    Score: 0.219
  4. The Impact of Exercise, Lifestyle, and Clinical Factors on Perceived Cognitive Function in Patients with Rheumatoid Arthritis: Results from a Prospective Cohort Study. ACR Open Rheumatol. 2019 Dec; 1(10):620-626.
    View in: PubMed
    Score: 0.216
  5. Correlates of Successful Rheumatoid Arthritis Flare Management: Clinician-driven Treatment, Home-based Strategies, and Medication Change. J Rheumatol. 2020 03; 47(3):333-340.
    View in: PubMed
    Score: 0.211
  6. Association of Changes in Anticitrullinated Protein Antibody Levels With Resource Use and Disease Activity Measures in Rheumatoid Arthritis Patients a US Observational Cohort. Clin Ther. 2019 06; 41(6):1057-1065.e3.
    View in: PubMed
    Score: 0.210
  7. A Development and Feasibility Study of a Peer Support Telephone Program in Rheumatoid Arthritis. J Clin Rheumatol. 2018 Sep; 24(6):346-349.
    View in: PubMed
    Score: 0.199
  8. Association of Low Bone Mineral Density with Anti-Citrullinated Protein Antibody Positivity and Disease Activity in Established Rheumatoid Arthritis: Findings from a US Observational Cohort. Adv Ther. 2018 02; 35(2):232-242.
    View in: PubMed
    Score: 0.191
  9. Association of anti-cyclic citrullinated protein antibodies, erosions, and rheumatoid factor with disease activity and work productivity: A patient registry study. Semin Arthritis Rheum. 2018 04; 47(5):630-638.
    View in: PubMed
    Score: 0.188
  10. Physical Activity and Correlates of Physical Activity Participation Over Three Years in Adults With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2017 10; 69(10):1535-1545.
    View in: PubMed
    Score: 0.186
  11. Effects of Achieving Target Measures in Rheumatoid Arthritis on Functional Status, Quality of Life, and Resource Utilization: Analysis of Clinical Practice Data. Arthritis Care Res (Hoboken). 2016 Mar; 68(3):308-17.
    View in: PubMed
    Score: 0.168
  12. Factors associated with attrition in a longitudinal rheumatoid arthritis registry. Arthritis Care Res (Hoboken). 2013 Jul; 65(7):1183-9.
    View in: PubMed
    Score: 0.139
  13. Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity. Arthritis Care Res (Hoboken). 2012 Dec; 64(12):1794-803.
    View in: PubMed
    Score: 0.134
  14. Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study. Rheumatology (Oxford). 2011 Jan; 50(1):40-6.
    View in: PubMed
    Score: 0.115
  15. Evaluation of selected rheumatoid arthritis activity scores for office-based assessment. J Rheumatol. 2010 Dec; 37(12):2466-8.
    View in: PubMed
    Score: 0.115
  16. TNFalpha inhibitors may improve asthma symptoms: a case series of 12 patients with rheumatoid arthritis and asthma. J Clin Rheumatol. 2009 Jun; 15(4):198-200.
    View in: PubMed
    Score: 0.105
  17. Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate. J Rheumatol. 2007 Sep; 34(9):1817-22.
    View in: PubMed
    Score: 0.092
  18. Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study. Ann Rheum Dis. 2008 Mar; 67(3):358-63.
    View in: PubMed
    Score: 0.092
  19. Opposing effects of the D70 mutation and the shared epitope in HLA-DR4 on disease activity and certain disease phenotypes in rheumatoid arthritis. Ann Rheum Dis. 2007 Nov; 66(11):1497-502.
    View in: PubMed
    Score: 0.091
  20. Agreement between patient report and medical record review for medications used for rheumatoid arthritis: the accuracy of self-reported medication information in patient registries. Arthritis Rheum. 2007 Mar 15; 57(2):234-9.
    View in: PubMed
    Score: 0.090
  21. Dietary caffeine intake does not affect methotrexate efficacy in patients with rheumatoid arthritis. J Rheumatol. 2006 Jul; 33(7):1275-81.
    View in: PubMed
    Score: 0.086
  22. Dr. Kremer et al reply. J Rheumatol. 2021 Oct 15.
    View in: PubMed
    Score: 0.062
  23. Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease. Blood Adv. 2021 09 14; 5(17):3445-3456.
    View in: PubMed
    Score: 0.062
  24. Divergence of Cardiovascular Biomarkers of Lipids and Subclinical Myocardial Injury Among Rheumatoid Arthritis Patients With Increased Inflammation. Arthritis Rheumatol. 2021 06; 73(6):970-979.
    View in: PubMed
    Score: 0.060
  25. Validation of the adjusted multi-biomarker disease activity score as a prognostic test for radiographic progression in rheumatoid arthritis: a combined analysis of multiple studies. Arthritis Res Ther. 2021 01 04; 23(1):1.
    View in: PubMed
    Score: 0.059
  26. The Clinical Disease Activity Index and the Routine Assessment of Patient Index Data 3 for Achievement of Treatment Strategies. J Rheumatol. 2020 Dec 15.
    View in: PubMed
    Score: 0.058
  27. Lifestyle and Clinical Risk Factors for Incident Rheumatoid Arthritis-associated Interstitial Lung Disease. J Rheumatol. 2021 05; 48(5):656-663.
    View in: PubMed
    Score: 0.058
  28. Rheumatoid arthritis-related lung disease detected on clinical chest computed tomography imaging: Prevalence, risk factors, and impact on mortality. Semin Arthritis Rheum. 2020 12; 50(6):1216-1225.
    View in: PubMed
    Score: 0.058
  29. Correction to: Association of rheumatoid arthritis-related autoantibodies with pulmonary function test abnormalities in a rheumatoid arthritis registry. Clin Rheumatol. 2020 04; 39(4):1371-1372.
    View in: PubMed
    Score: 0.056
  30. Genetic associations with radiological damage in rheumatoid arthritis: Meta-analysis of seven genome-wide association studies of 2,775 cases. PLoS One. 2019; 14(10):e0223246.
    View in: PubMed
    Score: 0.054
  31. Supplementing Claims Data with Electronic Medical Records to Improve Estimation and Classification of Rheumatoid Arthritis Disease Activity: A Machine Learning Approach. ACR Open Rheumatol. 2019 Nov; 1(9):552-559.
    View in: PubMed
    Score: 0.053
  32. Correction: Prevalence and predictors for sustained remission in rheumatoid arthritis. PLoS One. 2019; 14(8):e0221314.
    View in: PubMed
    Score: 0.053
  33. Association of rheumatoid arthritis-related autoantibodies with pulmonary function test abnormalities in a rheumatoid arthritis registry. Clin Rheumatol. 2019 12; 38(12):3401-3412.
    View in: PubMed
    Score: 0.053
  34. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study. Arthritis Rheumatol. 2019 09; 71(9):1472-1482.
    View in: PubMed
    Score: 0.053
  35. Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis. Pract Lab Med. 2019 Aug; 16:e00122.
    View in: PubMed
    Score: 0.052
  36. Adjustment of the multi-biomarker disease activity score to account for age, sex and adiposity in patients with rheumatoid arthritis. Rheumatology (Oxford). 2019 05 01; 58(5):874-883.
    View in: PubMed
    Score: 0.052
  37. Prevalence and predictors for sustained remission in rheumatoid arthritis. PLoS One. 2019; 14(4):e0214981.
    View in: PubMed
    Score: 0.052
  38. Incidence and predictors of dyspnea on exertion in a prospective cohort of patients with rheumatoid arthritis. ACR Open Rheumatol. 2019 Mar; 1(1):4-15.
    View in: PubMed
    Score: 0.052
  39. Impact of Changes in Inflammation on Estimated Ten-Year Cardiovascular Risk in Rheumatoid Arthritis. Arthritis Rheumatol. 2018 09; 70(9):1392-1398.
    View in: PubMed
    Score: 0.050
  40. Development of a Molecular Signature to Monitor Pharmacodynamic Responses Mediated by In Vivo Administration of Glucocorticoids. Arthritis Rheumatol. 2018 08; 70(8):1331-1342.
    View in: PubMed
    Score: 0.049
  41. Diet and Rheumatoid Arthritis Symptoms: Survey Results From a Rheumatoid Arthritis Registry. Arthritis Care Res (Hoboken). 2017 12; 69(12):1920-1925.
    View in: PubMed
    Score: 0.047
  42. Fibromyalgia and the Prediction of Two-Year Changes in Functional Status in Rheumatoid Arthritis Patients. Arthritis Care Res (Hoboken). 2017 12; 69(12):1871-1877.
    View in: PubMed
    Score: 0.047
  43. Drug safety analyses in a rheumatoid arthritis registry: application of different approaches regarding timing of exposure and confounder measurement. Arthritis Res Ther. 2017 06 13; 19(1):130.
    View in: PubMed
    Score: 0.046
  44. Validity of the Nurses' health study physical activity questionnaire in estimating physical activity in adults with rheumatoid arthritis. BMC Musculoskelet Disord. 2017 05 31; 18(1):234.
    View in: PubMed
    Score: 0.046
  45. Clinical patient registry recruitment and retention: a survey of patients in two chronic disease registries. BMC Med Res Methodol. 2017 Apr 17; 17(1):59.
    View in: PubMed
    Score: 0.045
  46. Different Rating of Global Rheumatoid Arthritis Disease Activity in Rheumatoid Arthritis Patients With Multiple Morbidities. Arthritis Rheumatol. 2017 04; 69(4):720-727.
    View in: PubMed
    Score: 0.045
  47. Erratum: Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis. Nat Commun. 2016 10 10; 7:13205.
    View in: PubMed
    Score: 0.044
  48. Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis. Nat Commun. 2016 08 23; 7:12460.
    View in: PubMed
    Score: 0.043
  49. Multibiomarker disease activity score and C-reactive protein in a cross-sectional observational study of patients with rheumatoid arthritis with and without concomitant fibromyalgia. Rheumatology (Oxford). 2016 Apr; 55(4):640-8.
    View in: PubMed
    Score: 0.041
  50. The impact of multimorbidity status on treatment response in rheumatoid arthritis patients initiating disease-modifying anti-rheumatic drugs. Rheumatology (Oxford). 2015 Nov; 54(11):2076-84.
    View in: PubMed
    Score: 0.040
  51. Development of a multimorbidity index: Impact on quality of life using a rheumatoid arthritis cohort. Semin Arthritis Rheum. 2015 Oct; 45(2):167-73.
    View in: PubMed
    Score: 0.040
  52. Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers. Am J Respir Crit Care Med. 2015 Jun 15; 191(12):1403-12.
    View in: PubMed
    Score: 0.040
  53. An external validation study reporting poor correlation between the claims-based index for rheumatoid arthritis severity and the disease activity score. Arthritis Res Ther. 2015 Apr 13; 17:83.
    View in: PubMed
    Score: 0.039
  54. Inconsistent treatment with disease-modifying antirheumatic drugs: a longitudinal data analysis. J Rheumatol. 2014 Dec; 41(12):2370-8.
    View in: PubMed
    Score: 0.038
  55. Clinical characteristics of RA patients with secondary SS and association with joint damage. Rheumatology (Oxford). 2015 May; 54(5):816-20.
    View in: PubMed
    Score: 0.038
  56. Behavioral and clinical factors associated with self-reported abnormal Papanicolaou tests in rheumatoid arthritis. J Womens Health (Larchmt). 2014 Sep; 23(9):771-6.
    View in: PubMed
    Score: 0.038
  57. Do rheumatologists know best? An outcomes study of inconsistent users of disease-modifying anti-rheumatic drugs. Semin Arthritis Rheum. 2015 Feb; 44(4):399-404.
    View in: PubMed
    Score: 0.038
  58. Subgrouping of patients with rheumatoid arthritis based on pain, fatigue, inflammation, and psychosocial factors. Arthritis Rheumatol. 2014 Aug; 66(8):2006-14.
    View in: PubMed
    Score: 0.038
  59. Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis. Chest. 2014 Jul; 146(1):41-50.
    View in: PubMed
    Score: 0.037
  60. Bronchiectasis. A late feature of severe rheumatoid arthritis. Medicine (Baltimore). 1994 May; 73(3):161-70.
    View in: PubMed
    Score: 0.037
  61. Rheumatoid arthritis quality measures and radiographic progression. Semin Arthritis Rheum. 2014 Aug; 44(1):9-13.
    View in: PubMed
    Score: 0.036
  62. The influence of polygenic risk scores on heritability of anti-CCP level in RA. Genes Immun. 2014 Mar; 15(2):107-14.
    View in: PubMed
    Score: 0.036
  63. Flares in rheumatoid arthritis: frequency and management. A report from the BRASS registry. J Rheumatol. 2014 Feb; 41(2):227-34.
    View in: PubMed
    Score: 0.036
  64. Automatic prediction of rheumatoid arthritis disease activity from the electronic medical records. PLoS One. 2013; 8(8):e69932.
    View in: PubMed
    Score: 0.035
  65. Development of a multi-biomarker disease activity test for rheumatoid arthritis. PLoS One. 2013; 8(4):e60635.
    View in: PubMed
    Score: 0.034
  66. Performance of matrix-based risk models for rapid radiographic progression in a cohort of patients with established rheumatoid arthritis. Arthritis Care Res (Hoboken). 2013 Apr; 65(4):526-33.
    View in: PubMed
    Score: 0.034
  67. Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis. PLoS Genet. 2013 Mar; 9(3):e1003394.
    View in: PubMed
    Score: 0.034
  68. Sustained rheumatoid arthritis remission is uncommon in clinical practice. Arthritis Res Ther. 2012 Mar 19; 14(2):R68.
    View in: PubMed
    Score: 0.032
  69. PTPN22.6, a dominant negative isoform of PTPN22 and potential biomarker of rheumatoid arthritis. PLoS One. 2012; 7(3):e33067.
    View in: PubMed
    Score: 0.032
  70. Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis. Arthritis Res Ther. 2012 Mar 05; 14(2):R43.
    View in: PubMed
    Score: 0.032
  71. Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort. Ann Rheum Dis. 2012 May; 71(5):681-6.
    View in: PubMed
    Score: 0.031
  72. Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study. Arthritis Res Ther. 2011 Jun 08; 13(3):R83.
    View in: PubMed
    Score: 0.030
  73. Erroneous augmentation of multiplex assay measurements in patients with rheumatoid arthritis due to heterophilic binding by serum rheumatoid factor. Arthritis Rheum. 2011 Apr; 63(4):894-903.
    View in: PubMed
    Score: 0.030
  74. Clinical predictors of erosion-free status in rheumatoid arthritis: a prospective cohort study. Rheumatology (Oxford). 2011 Aug; 50(8):1473-9.
    View in: PubMed
    Score: 0.030
  75. A functional RANKL polymorphism associated with younger age at onset of rheumatoid arthritis. Arthritis Rheum. 2010 Oct; 62(10):2864-75.
    View in: PubMed
    Score: 0.029
  76. A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries. Semin Arthritis Rheum. 2010 Aug; 40(1):2-14.e1.
    View in: PubMed
    Score: 0.028
  77. Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis Rheum. 2010 Aug; 62(8):2239-48.
    View in: PubMed
    Score: 0.028
  78. Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy. Arthritis Rheum. 2010 Jul; 62(7):1849-61.
    View in: PubMed
    Score: 0.028
  79. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet. 2010 Jun; 42(6):508-14.
    View in: PubMed
    Score: 0.028
  80. Hand bone mineral density is associated with both total hip and lumbar spine bone mineral density in post-menopausal women with RA. Rheumatology (Oxford). 2010 Mar; 49(3):513-9.
    View in: PubMed
    Score: 0.027
  81. Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat Genet. 2009 Dec; 41(12):1313-8.
    View in: PubMed
    Score: 0.027
  82. De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nat Genet. 2009 Aug; 41(8):931-5.
    View in: PubMed
    Score: 0.026
  83. The relationship between focal erosions and generalized osteoporosis in postmenopausal women with rheumatoid arthritis. Arthritis Rheum. 2009 Jun; 60(6):1624-31.
    View in: PubMed
    Score: 0.026
  84. Genome-wide association study of determinants of anti-cyclic citrullinated peptide antibody titer in adults with rheumatoid arthritis. Mol Med. 2009 May-Jun; 15(5-6):136-43.
    View in: PubMed
    Score: 0.026
  85. Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate. Rheumatology (Oxford). 2009 Jun; 48(6):613-7.
    View in: PubMed
    Score: 0.026
  86. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet. 2008 Oct; 40(10):1216-23.
    View in: PubMed
    Score: 0.025
  87. Predictors of discontinuation of tumor necrosis factor inhibitors in patients with rheumatoid arthritis. J Rheumatol. 2008 Sep; 35(9):1737-44.
    View in: PubMed
    Score: 0.025
  88. A broad analysis of IL1 polymorphism and rheumatoid arthritis. Arthritis Rheum. 2008 Jul; 58(7):1947-57.
    View in: PubMed
    Score: 0.025
  89. Biological significance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis. Ann Intern Med. 2008 Mar 04; 148(5):403; author reply 403-4.
    View in: PubMed
    Score: 0.024
  90. HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal Biochem. 2008 May 01; 376(1):1-12.
    View in: PubMed
    Score: 0.024
  91. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet. 2007 Dec; 39(12):1477-82.
    View in: PubMed
    Score: 0.024
  92. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006 Aug; 38(8):904-9.
    View in: PubMed
    Score: 0.022
  93. The validity of a rheumatoid arthritis medical records-based index of severity compared with the DAS28. Arthritis Res Ther. 2006; 8(3):R57.
    View in: PubMed
    Score: 0.021
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.